Dengue, chikungunya, and Zika share one vector and nearly identical early symptoms — but require very different responses. Here's what the 2025–2026 data tells us, and why precise differentiation matters more than ever.
Four macro trends redefining how infectious diseases are diagnosed, treated, and monitored worldwide. The dust has settled in Munich following one of the most pivotal annual gatherings for clinical microbiology and infectious diseases. While the halls of the convention center have emptied, the echoes of the technological breakthroughs showcased there are just beginning to reshape the healthcare landscape. For years, the diagnostics industry operated on a predictable trajectory: one patient, one suspected pathogen, one test. But global health shifts—accelerated by climate change, skyrocketing antimicrobial resistance (AMR), and the urgent need to reduce hospital turnaround times—have reshaped that traditional paradigm. Here are four macro trends coming out of the exhibition that are redefining how we diagnose, treat, and monitor infectious diseases worldwide.
The 79th World Health Assembly (WHA79), convening in Geneva in May 2026, marks a pivotal transition in global health governance. Moving past the initial reactive phase of the post-pandemic era, international health policies are now shifting toward structural entrenchment. For the In Vitro Diagnostics (IVD) sector, policy is no longer just a regulatory hurdle—it is a market creator.
As the world unites around International Women’s Health Day on May 18, the WHO’s 2030 strategy to eliminate cervical cancer stands as both a moral mission and one of the most compelling economic growth strategies of the decade.
Recently, the BioPerfectus Influenza A Virus (H1N1 & H3) Real Time PCR Kit received approval from China’s National Medical Products Administration (NMPA).
As the Southern Hemisphere transitions into autumn and winter, the 2026 respiratory virus season arrives carrying two parallel challenges.
April 25 marks World Malaria Day 2026. Explore the latest WHO data, global progress, remaining challenges, and what it takes to end malaria for good
As the year draws to a close and the Lunar New Year approaches, we stand once again at a moment of renewal. The idea of a “new year” carries a quiet but powerful meaning—no matter what the past has held, it invites us to reset our focus, regain momentum, and move forward with clarity and confidence.
BioPerfectus collaborates with Mongolia’s National Center of Communicable Diseases to strengthen infectious disease surveillance through reliable molecular diagnostic PCR assays, supporting rapid public-health response.
We are excited to share that the Bioperfectus Monkeypox Virus (MPXV) Fast Real Time PCR Kit has been officially listed under the WHO Emergency Use Listing (EUL) as of December 3, 2025.
